Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CELC NASDAQ:GH NASDAQ:RDNT NASDAQ:SHC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCELCCelcuity$51.23-6.2%$30.93$7.57▼$55.44$2.17B0.721.08 million shs731,213 shsGHGuardant Health$67.42+4.6%$52.07$20.14▼$67.51$8.41B1.452.80 million shs2.86 million shsRDNTRadNet$71.760.0%$60.21$45.00▼$93.65$5.52B1.541.05 million shs627,715 shsSHCSotera Health$16.37+1.0%$12.98$9.53▼$17.08$4.65B1.831.77 million shs1.03 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCELCCelcuity0.00%+4.02%+28.36%+329.06%+220.99%GHGuardant Health0.00%+8.95%+62.77%+47.24%+163.57%RDNTRadNet0.00%+3.12%+31.21%+22.25%+8.25%SHCSotera Health0.00%-0.12%+46.82%+33.31%+6.02%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCELCCelcuity1.7559 of 5 stars2.52.00.00.03.13.30.0GHGuardant Health3.2072 of 5 stars1.52.00.04.43.52.50.6RDNTRadNet3.1835 of 5 stars1.62.00.04.64.12.50.0SHCSotera Health1.8371 of 5 stars1.40.00.00.04.04.21.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCELCCelcuity 3.00Buy$56.5010.29% UpsideGHGuardant Health 3.06Buy$57.50-14.71% DownsideRDNTRadNet 3.25Buy$71.60-0.22% DownsideSHCSotera Health 2.80Moderate Buy$16.00-2.26% DownsideCurrent Analyst Ratings BreakdownLatest CELC, GH, RDNT, and SHC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/18/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$50.00 ➝ $66.008/18/2025RDNTRadNetZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/15/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$74.00 ➝ $70.008/13/2025RDNTRadNetRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingStrong-Buy ➝ Strong-Buy$66.00 ➝ $75.008/11/2025RDNTRadNetMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeOverweight8/8/2025SHCSotera HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight7/31/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$57.00 ➝ $60.007/31/2025GHGuardant HealthRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$59.00 ➝ $61.007/28/2025CELCCelcuityLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$28.00 ➝ $60.007/28/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$27.00 ➝ $50.007/28/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.00(Data available from 9/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCELCCelcuityN/AN/AN/AN/A$3.11 per shareN/AGHGuardant Health$739.02M11.38N/AN/A($1.13) per share-59.66RDNTRadNet$1.83B3.02$3.48 per share20.60$15.31 per share4.69SHCSotera Health$1.10B4.23$1.20 per share13.63$1.43 per share11.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCELCCelcuity-$111.78M-$3.45N/AN/AN/AN/A-150.07%-64.67%11/13/2025 (Estimated)GHGuardant Health-$436.37M-$3.35N/AN/AN/A-49.93%N/A-28.95%11/5/2025 (Estimated)RDNTRadNet$2.79M-$0.20N/A135.40N/A-0.78%2.41%0.82%11/10/2025 (Estimated)SHCSotera Health$44.34M$0.08204.6523.39N/A2.14%39.42%5.66%11/4/2025 (Estimated)Latest CELC, GH, RDNT, and SHC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025CELCCelcuity-$0.90-$1.04-$0.14-$1.04N/AN/A8/10/2025Q2 2025RDNTRadNet$0.17$0.31+$0.14$0.43$488.06 million$498.23 million8/8/2025Q2 2025SHCSotera Health$0.17$0.20+$0.03$0.03$275.81 million$294.34 million7/30/2025Q2 2025GHGuardant Health-$0.52-$0.44+$0.08-$0.80$211.19 million$232.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCELCCelcuityN/AN/AN/AN/AN/AGHGuardant HealthN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ASHCSotera HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCELCCelcuity2.244.584.58GHGuardant HealthN/A3.713.35RDNTRadNet0.912.002.00SHCSotera Health4.492.472.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCELCCelcuity63.33%GHGuardant Health92.60%RDNTRadNet77.90%SHCSotera Health91.03%Insider OwnershipCompanyInsider OwnershipCELCCelcuity15.78%GHGuardant Health6.10%RDNTRadNet5.60%SHCSotera Health55.12%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCELCCelcuity4042.43 million35.73 millionOptionableGHGuardant Health2,021124.71 million117.10 millionNot OptionableRDNTRadNet11,02176.92 million72.61 millionOptionableSHCSotera Health3,000284.05 million127.48 millionOptionableCELC, GH, RDNT, and SHC HeadlinesRecent News About These CompaniesSotera Health Company $SHC is Sculptor Capital LP's 8th Largest PositionSeptember 1 at 7:14 AM | marketbeat.comInvesco Ltd. Has $3.57 Million Stock Holdings in Sotera Health Company $SHCAugust 31 at 3:14 AM | marketbeat.comCampbell & CO Investment Adviser LLC Raises Position in Sotera Health Company $SHCAugust 29, 2025 | marketbeat.comNuveen LLC Invests $4.43 Million in Sotera Health Company $SHCAugust 29, 2025 | marketbeat.comPresident Sterigenics Of Sotera Health Sold $2.07M In StockAugust 28, 2025 | benzinga.com46,132 Shares in Sotera Health Company $SHC Acquired by AlphaQuest LLCAugust 28, 2025 | marketbeat.comShould You Buy Sotera Health Company (SHC) After Golden Cross?August 27, 2025 | zacks.comSotera Health (NASDAQ:SHC) Insider Michael Rutz Sells 126,611 SharesAugust 27, 2025 | insidertrades.comSotera Health Company $SHC Shares Acquired by Charles Schwab Investment Management Inc.August 25, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Has $93.81 Million Stock Holdings in Sotera Health Company $SHCAugust 24, 2025 | marketbeat.comDeutsche Bank AG Acquires 157,334 Shares of Sotera Health Company $SHCAugust 24, 2025 | marketbeat.comSotera Health Company (NASDAQ:SHC) Receives $16.00 Consensus PT from AnalystsAugust 24, 2025 | americanbankingnews.comVanguard Group Inc. Trims Stock Holdings in Sotera Health Company $SHCAugust 23, 2025 | marketbeat.comSotera Health Company (NASDAQ:SHC) Given Average Rating of "Moderate Buy" by BrokeragesAugust 23, 2025 | marketbeat.comResearch Tools & Consumables Stocks Q2 Earnings: Sotera Health Company (NASDAQ:SHC) Best of the BunchAugust 21, 2025 | finance.yahoo.comMIG Capital LLC Has $59.63 Million Stock Holdings in Sotera Health Company $SHCAugust 21, 2025 | marketbeat.comWolfe Research Sticks to Its Buy Rating for Sotera Health (SHC)August 17, 2025 | theglobeandmail.comSotera Health (NASDAQ:SHC) Rating Increased to Strong-Buy at Wall Street ZenAugust 17, 2025 | marketbeat.comSome May Be Optimistic About Sotera Health's (NASDAQ:SHC) EarningsAugust 16, 2025 | finance.yahoo.comSotera Health’s Earnings Call Highlights Growth and OptimismAugust 13, 2025 | msn.comSotera Health Company (NASDAQ:SHC) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesCatalysts Align: Archer Beats Estimates, Delivers Aircraft to UAEBy Jeffrey Neal Johnson | August 13, 20255 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyBy Jordan Chussler | August 9, 2025Oracle’s 2025 Rally Is Only Half Over: 5 Reasons WhyBy Thomas Hughes | August 11, 2025Can AI Defense Contracts Push Palantir Shares Higher?By Chris Markoch | August 19, 2025CELC, GH, RDNT, and SHC Company DescriptionsCelcuity NASDAQ:CELC$51.23 -3.37 (-6.17%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$52.00 +0.77 (+1.50%) As of 08/29/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.Guardant Health NASDAQ:GH$67.42 +2.95 (+4.58%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$67.32 -0.10 (-0.15%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.RadNet NASDAQ:RDNT$71.76 -0.03 (-0.04%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$70.96 -0.80 (-1.11%) As of 08/29/2025 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Sotera Health NASDAQ:SHC$16.37 +0.17 (+1.05%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$16.37 0.00 (0.00%) As of 08/29/2025 06:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Tencent Music Stock Outshines Spotify as China’s Music Giant With Shares Near Highs, Here's to Watch in Broadcom's Q3 Report Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
